Hinweis-Modus ist eingeschaltet Ausschalten

BTEC - iShares Nasdaq US Biotechnology UCITS ETF (IE00BYXG2H39)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

FINDEN, SPEICHERN & VERFOLGEN SIE INVESTITIONEN MIT DER CBONDS WATCHLIST

Dank der Cbonds Watchlist bleiben Sie stets über Ihre Investitionen informiert und können fundierte Entscheidungen treffen!

Watchlist
Sie benötigen einen Zugang
 
(%)
IE00BYXG2H39
BTEC ISIN
Exchange Traded Funds (ETF)
Fondstyp
BlackRock
Anbieter
9,91 USD
NAV pro Aktie | 14/08/2026
19/10/2017
Startdatum
Nein
Ausschüttung von Dividenden
CEOGMS
CFI
BTEC
Ticker
Formed
Status
Equity
Investitionsobjekt
Biotech
Sektor
USA
Geographie
Nasdaq Biotechnology Index
Benchmark
0.35 %
Gesamtkostenquote
1.146,15 Mio. USD
Gesamtes Fondsvermögen | 14/08/2026
1.068,75 Mio. USD
Aktien-Anlageklasse Volumen | 14/08/2026
Ja
UCITS

Letzte Daten zum
Zum Vergleichen hinzufügen

Kurse (BTEC)

Entdecken Sie die umfangreichste Datenbank

1 000 000

Anleihen weltweit

100 000

Aktien

175 910

ETF & Funds

100 000

Indizes

Verwalten Sie Ihr Portfolio auf effizienteste Weise

  • Bond-Screener
  • Watchlist
  • Excel-Add-In

Kurs-Dynamik

Fund profile

The iShares Nasdaq US Biotechnology UCITS ETF seeks to replicate as close as possible the price and yield performance of the NASDAQ Biotechnology Index by investing in a portfolio comprised primarily of biotechnology and pharmaceutical equities listed on the NASDAQ

BTEC profile

The iShares Nasdaq US Biotechnology UCITS ETF is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in USA. The BlackRock fund’s base currency is USD and the share class was registered 19.10.2017 with unique ISIN - IE00BYXG2H39. Main exchange is London S.E. (USD) and ticker symbol is BTEC. The total expense ratio is 0.35%. The iShares Nasdaq US Biotechnology UCITS ETF pays dividends 0 time(s) per year.

Struktur BTEC auf 28/07/2026

Wertpapier Wertpapier
AMGEN INC 8,57%
VERTEX PHARMACEUTICALS INC 8,05%
GILEAD SCIENCES INC 7,34%
REGENERON PHARMACEUTICALS INC 5,02%
REVOLUTION MEDICINES INC 2,74%
ALNYLAM PHARMACEUTICALS INC 2,7%
BIOGEN INC 2,13%
ILLUMINA INC 2,05%
ROYALTY PHARMA PLC CLASS A 1,86%
INCYTE CORP 1,82%
ROIVANT SCIENCES LTD 1,71%
ARGENX SE ADR 1,69%
INSMED INC 1,58%
UNITED THERAPEUTICS CORP 1,56%
MODERNA INC 1,55%
VIATRIS INC 1,46%
GUARDANT HEALTH INC 1,33%
NEUROCRINE BIOSCIENCES INC 1,29%
BRIDGEBIO PHARMA INC 1,17%
MEDPACE HOLDINGS INC 1,14%
JAZZ PHARMACEUTICALS PLC 1,13%
ASCENDIS PHARMA 1,1%
EXELIXIS INC 1%
MADRIGAL PHARMACEUTICALS INC 0,87%
ARROWHEAD PHARMACEUTICALS INC 0,85%
AXSOME THERAPEUTICS INC 0,85%
BIOMARIN PHARMACEUTICAL INC 0,84%
BEONE MEDICINES AG 0,76%
CYTOKINETICS INC 0,75%
BIONTECH SE ADR 0,75%
KRYSTAL BIOTECH INC 0,75%
SANOFI ADR REPRESENTING SA 0,74%
HALOZYME THERAPEUTICS INC 0,69%
SUMMIT THERAPEUTICS INC 0,68%
IONIS PHARMACEUTICALS INC 0,64%
CRINETICS PHARMACEUTICALS INC 0,62%
PROTAGONIST THERAPEUTICS INC 0,62%
KYMERA THERAPEUTICS INC 0,61%
SPYRE THERAPEUTICS INC 0,61%
ALKERMES 0,59%
APOGEE THERAPEUTICS INC 0,58%
PRAXIS PRECISION MEDICINES INC 0,58%
IMMUNOVANT INC 0,56%
VAXCYTE INC 0,55%
TEMPUS AI INC CLASS A 0,52%
RHYTHM PHARMACEUTICALS INC 0,52%
IMMUNITYBIO INC 0,51%
ABIVAX AMERICAN DEPOSITARY SHARES 0,5%
COGENT BIOSCIENCES INC 0,49%
MIRUM PHARMACEUTICALS INC 0,48%
CG ONCOLOGY INC 0,45%
XENON PHARMACEUTICALS INC 0,44%
PTC THERAPEUTICS INC 0,44%
AMNEAL PHARMACEUTICALS INC CLASS A 0,42%
LIGAND PHARMACEUTICALS INC 0,42%
SCHOLAR ROCK HOLDING CORP 0,41%
ERASCA INC 0,4%
TWIST BIOSCIENCE CORP 0,39%
10X GENOMICS INC CLASS A 0,39%
ORUKA THERAPEUTICS INC 0,38%
TRAVERE THERAPEUTICS INC 0,37%
INDIVIOR PHARMACEUTICALS INC 0,35%
CRISPR THERAPEUTICS AG 0,32%
DEFINIUM THERAPEUTICS INC 0,32%
ACADIA PHARMACEUTICALS INC 0,31%
VERACYTE INC 0,31%
CARIS LIFE SCIENCES INC 0,31%
EDGEWISE THERAPEUTICS INC 0,31%
DYNE THERAPEUTICS INC 0,3%
RELAY THERAPEUTICS INC 0,28%
TANGO THERAPEUTICS INC 0,27%
DENALI THERAPEUTICS INC 0,27%
STRUCTURE THERAPEUTICS ADR INC 0,26%
ADAPTIVE BIOTECHNOLOGIES CORP 0,25%
KINIKSA PHARMACEUTICALS INTERNATIO 0,25%
ARCUTIS BIOTHERAPEUTICS INC 0,25%
ENLIVEN THERAPEUTICS INC 0,23%
ALUMIS INC 0,23%
NEWAMSTERDAM PHARMA NV 0,23%
IDEAYA BIOSCIENCES INC 0,22%
MBX BIOSCIENCES INC 0,2%
DISC MEDICINE INC 0,2%
SUPERNUS PHARMACEUTICALS INC 0,19%
GRAIL INC 0,19%
BEAM THERAPEUTICS INC 0,19%
ATAIBECKLEY INC 0,19%
TREVI THERAPEUTICS INC 0,18%
KODIAK SCIENCES INC 0,18%
ULTRAGENYX PHARMACEUTICAL INC 0,18%
NURIX THERAPEUTICS INC 0,18%
TARSUS PHARMACEUTICALS INC 0,18%
BIOCRYST PHARMACEUTICALS INC 0,17%
VERICEL CORP 0,17%
VERA THERAPEUTICS INC CLASS A 0,17%
UNIQURE NV 0,16%
PHARVARIS N V NV 0,16%
MINERALYS THERAPEUTICS INC 0,16%
AMYLYX PHARMACEUTICALS INC 0,15%
GENMAB SPONSORED ADR 0,15%
AGIOS PHARMACEUTICALS INC 0,15%
Andere - %

Andere ETFs und Fonds dieses Anbieters

Ähnliche Etf & Fonds

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} Mio.
    NAV
    {{ item.expense_ratio }}
    Gesamtkostenquote
Sie müssen sich registrieren , um Zugriff zu erhalten.